Capstone Investment Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,419
| Closed | -$465K | – | 1956 |
|
|
2024
Q4 | $465K | Sell |
1,419
-621
| -30% | -$195K | ﹤0.01% | 1340 |
|
|
2024
Q3 | $612K | Sell |
2,040
-731
| -26% | -$224K | 0.01% | 1138 |
|
|
2024
Q2 | $913K | Buy |
2,771
+785
| +40% | +$277K | 0.02% | 1029 |
|
|
2024
Q1 | $786K | Sell |
1,986
-272
| -12% | -$101K | 0.01% | 1289 |
|
|
2023
Q4 | $795K | Buy |
+2,258
| New | +$799K | 0.01% | 1140 |
|
|
2023
Q3 | – | Sell |
-883
| Closed | -$341K | – | 2354 |
|
|
2023
Q2 | $338K | Buy |
+883
| New | +$315K | 0.01% | 1342 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1744 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1792 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2258 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2302 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2186 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2178 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2139 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2154 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1950 |
|
|
2018
Q1 | – | Sell |
-3,760
| Closed | -$370K | – | 570 |
|
|
2017
Q4 | $370K | Buy |
+3,760
| New | +$369K | 0.02% | 325 |
|
|
2017
Q3 | – | Sell |
-21,760
| Closed | -$2.06M | – | 769 |
|
|
2017
Q2 | $2.06M | Buy |
21,760
+2,756
| +15% | +$253K | 0.1% | 247 |
|
|
2017
Q1 | $1.55M | Buy |
+19,004
| New | +$1.59M | 0.08% | 335 |
|
|
2016
Q4 | – | Sell |
-18,995
| Closed | -$1.42M | – | 1159 |
|
|
2016
Q3 | $1.42M | Buy |
+18,995
| New | +$1.51M | 0.07% | 319 |
|
Other funds holding WST
DCP
